Ronald M. Kurtz M.D., Chief Medical Officer at RxSight, Inc. (RXST), sold 5,100 shares at $6.96 ($35K) on 2026-09-02, disclosed to the SEC on 2026-09-02.
Open-market sale of $35k RXST by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RXST | SELL | 2023-12-29 | $1.8M | — | Filing → |
| RXST | SELL | 2023-12-18 | $1.6M | — | Filing → |
| RXST | BUY | 2021-08-05 | $2.1M | — | Filing → |